Categories LATEST, Technology

Stranger Things season 3 is driving Netflix stock

Netflix (NASDAQ: NFLX) is proving time and again why it is the best at original content streaming. In yet another show of success, the company announced late on Monday record viewership for the third and latest season of science fiction horror web series Stranger Things.

On its official Twitter account, the Los Gatos, California-based firm said, “40.7 million household accounts have been watching the show since its July 4 global launch — more than any other film or series in its first four days. And 18.2 million have already finished the entire season.”

stranger things netflix

The previous season of the show, created by the Duffer Brothers, had only about 15 million viewers in the first three days.  

The record-breaking viewership resonated in the stock market as well, with NFLX stock climbing almost 2% on Tuesday. Netflix shares have gained 43% since the beginning of this year.

The announcement was followed by an optimistic note by Justin Patterson of Raymond James, who said the viewership accounts for 26% of the streaming service’s overall paid subscriber base.      

READ: Has Roku run out of its firepower? Not necessarily

“As the content breadth and quality improve and drive more engagement, we see further pricing upside,” he added.

In general, the market is highly optimistic on the stock, with 24 out of 30 analysts recommending Buy. The stock has a 12-month average price target of $422.32, suggesting a 12% upside from the last close.

The streaming giant is slated to report second-quarter financial results on July 17, Wednesday.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Cost reduction has become a priority for FedEx (FDX) after a challenging quarter

Shares of FedEx Corporation (NYSE: FDX) were up 1% on Tuesday. The stock has dropped 44% year-to-date and 34% over the past 12 months. The company delivered mixed results for

Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know

After a soft start to the year, the IPO market has witnessed muted activity so far though a few big companies entered the stock market. On the heels of AIG

Stock Watch: Is Darden Restaurants a good buy after earnings?

After a prolonged slowdown, the restaurant industry is returning to normal patterns but macroeconomic uncertainties and high inflation are currently playing spoilsport for it. While the pandemic-related slump forced many

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top